The Mantle Cell Lymphoma Therapeutics Global Market Report 2023, provides comprehensive information on the mantle cell lymphoma therapeutics market across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa for the 27 major global industries. The report covers a ten year historic period – 2010-2021, and a ten year forecast period – 2023-2032.
Learn More On The Mantle Cell Lymphoma Therapeutics Market’s Growth:
The global mantle cell lymphoma therapeutics market size is expected to grow from $2.08 billion in 2022 to $2.26 billion in 2023 at a compound annual growth rate (CAGR) of 8.8%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global mantle cell lymphoma therapeutics market size is expected to reach $3.04 billion in 2027 at a CAGR of 7.7%.
Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample_request?id=10813&type=smp
The development of targeted therapy drugs is a key trend gaining popularity in the mantle cell lymphoma therapeutics market. Major companies operating in the mantle cell lymphoma therapeutics market are developing new drugs for targeted therapy to sustain their position in the market. For instance, in March 2023, AstraZeneca plc., a UK-based pharmaceutical company, received approval for Calquence (acalabrutinib) from National Medical Products Administration (NMPA) to market the drug in China for adult patients who have mantle cell lymphoma (MCL). Calquence (acalabrutinib) is a selective Bruton’s tyrosine kinase (BTK) inhibitor, and it is used to offer a tolerable and effective new treatment option to help control mantle cell lymphoma.
The mantle cell lymphoma therapeutics market is segmented:
1) By Type: Combination Therapy, Monotherapy
2) By Mechanism of Action: Bruton Tyrosine Kinase Inhibitors, Alkylating Agents, Deoxyribonucleic Acid Synthesis Inhibitors, Microtubule Inhibitors, Monoclonal Antibodies, Other Mechanisms
3) By Route of Administration: Oral, Parenteral
4) By Application: Hospital, Research Institute, Other Applications
North America was the largest region in the mantle cell lymphoma therapeutics market in 2022.
The table of contents in TBRC’s mantle cell lymphoma therapeutics market report includes:
- Executive Summary
- Mantle Cell Lymphoma Therapeutics Market Characteristics
- Mantle Cell Lymphoma Therapeutics Market Trends And Strategies
- Mantle Cell Lymphoma Therapeutics Market – Macro Economic Scenario
- Mantle Cell Lymphoma Therapeutics Market Size And Growth
.
.
.
- Middle East Mantle Cell Lymphoma Therapeutics Market
- Africa Mantle Cell Lymphoma Therapeutics Market
- Mantle Cell Lymphoma Therapeutics Market Competitive Landscape And Company Profiles
- Key Mergers And Acquisitions In The Mantle Cell Lymphoma Therapeutics Market
- Mantle Cell Lymphoma Therapeutics Market Future Outlook and Potential Analysis
Top Major Players
- AstraZeneca plc
- Celgene Corporation
- Johnson & Johnson Consumer Inc.
- Takeda Pharmaceutical Company Limited
- Bayer AG
Learn About Us:
The Business Research Company is a market intelligence firm that pioneers in market, company, and consumer research. TBRC’s specialist consultants are located globally and are experts in a wide range of industries that include healthcare, manufacturing, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries. Through the report businesses can gain a thorough understanding of the market’s size, growth rate, major drivers and leading players.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
